SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (68)8/9/2003 3:08:49 PM
From: Icebrg  Read Replies (1) of 295
 
>> There was an abstract as ASCO this year giving some background on the stratification done in the trial>>

There are - it turns out - also some slides from the presentation given by Dr. Escudier. Some more meat for the bones, but nothing mind-boggling.

If nothing else, the "drug" appears to be extremely safe. There had, at the time of the presentation at ASCO - when the study had almost been concluded, only been recorded three serious adverse events, which according to the investigator might have been caused by Neovastat (or the placebo).

Erik

media.asco.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News